全文获取类型
收费全文 | 5360篇 |
免费 | 365篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 255篇 |
妇产科学 | 46篇 |
基础医学 | 570篇 |
口腔科学 | 94篇 |
临床医学 | 708篇 |
内科学 | 1065篇 |
皮肤病学 | 38篇 |
神经病学 | 606篇 |
特种医学 | 507篇 |
外科学 | 526篇 |
综合类 | 73篇 |
一般理论 | 3篇 |
预防医学 | 514篇 |
眼科学 | 249篇 |
药学 | 297篇 |
肿瘤学 | 175篇 |
出版年
2021年 | 61篇 |
2019年 | 56篇 |
2018年 | 75篇 |
2017年 | 49篇 |
2016年 | 76篇 |
2015年 | 50篇 |
2014年 | 83篇 |
2013年 | 128篇 |
2012年 | 174篇 |
2011年 | 195篇 |
2010年 | 148篇 |
2009年 | 111篇 |
2008年 | 197篇 |
2007年 | 208篇 |
2006年 | 196篇 |
2005年 | 181篇 |
2004年 | 197篇 |
2003年 | 169篇 |
2002年 | 171篇 |
2001年 | 166篇 |
2000年 | 161篇 |
1999年 | 139篇 |
1998年 | 88篇 |
1997年 | 75篇 |
1996年 | 83篇 |
1995年 | 53篇 |
1994年 | 61篇 |
1993年 | 46篇 |
1992年 | 125篇 |
1991年 | 121篇 |
1990年 | 133篇 |
1989年 | 136篇 |
1988年 | 147篇 |
1987年 | 142篇 |
1986年 | 159篇 |
1985年 | 134篇 |
1984年 | 93篇 |
1983年 | 98篇 |
1982年 | 75篇 |
1981年 | 61篇 |
1980年 | 58篇 |
1979年 | 96篇 |
1978年 | 79篇 |
1977年 | 67篇 |
1976年 | 53篇 |
1975年 | 48篇 |
1974年 | 55篇 |
1973年 | 52篇 |
1970年 | 43篇 |
1968年 | 42篇 |
排序方式: 共有5750条查询结果,搜索用时 31 毫秒
991.
992.
Croen LA Connors SL Matevia M Qian Y Newschaffer C Zimmerman AW 《Journal of Neurodevelopmental Disorders》2011,3(4):307-315
This study aims to investigate the association between prenatal exposure to terbutaline and other β2 adrenergic receptor (B2AR) agonists and autism spectrum disorders (ASDs). The methodology used is a case–control study among children born from 1995 to 1999 at Kaiser Permanente Northern California hospitals. Cases (n = 291) were children with an ASD diagnosis; controls (n = 284) were children without ASDs, randomly sampled and frequency-matched to cases on sex, birth year, and delivery hospital. Exposure to B2AR agonists during 30 days prior to conception and each trimester of pregnancy was ascertained from prenatal medical records and health plan databases. The frequency of exposure to any B2AR agonist during pregnancy was similar for mothers of children with ASD and mothers of controls (18.9% vs. 14.8%, P = 0.19). Exposure to B2AR agonists other than terbutaline was not associated with an increased risk for ASDs. However, terbutaline exposure for >2 days during the third trimester was associated with more than a fourfold increased risk for ASDs independent of indication although the limited sample size resulted in an imprecise and nonsignificant effect estimate (ORadj = 4.4; 95% confidence interval, 0.8–24.6). This analysis does not offer evidence linking B2AR exposure in pregnancy with autism risk. However, exposure to terbutaline during the third trimester for >2 days may be associated with an increased risk of autism. Should this result be confirmed in larger samples, it would point to late pregnancy as an etiologic window of interest in autism risk factor research. 相似文献
993.
Wong RP Karunajeewa H Mueller I Siba P Zimmerman PA Davis TM 《Antimicrobial agents and chemotherapy》2011,55(2):798-805
Surveillance for Plasmodium falciparum drug resistance mutations is becoming an established tool for assessing antimalarial treatment effectiveness. We used an extended version of a high-throughput post-PCR multiplexed ligase detection reaction fluorescent microsphere assay (LDR-FMA) to detect single-nucleotide P. falciparum drug resistance polymorphisms in 402 isolates from children in Papua New Guinea (PNG) participating in an antimalarial treatment trial. There was a fixation of P. falciparum crt (pfcrt) K76T, pfdhfr C59R and S108N, and pfmdr1 mutations (92%, 93%, 95%, and 91%, respectively). Multiple mutations were frequent. Eighty-eight percent of isolates possessed a quintuple mutation (underlined), SVMNT, NRNI, KAA, and YYSND, in codons 72 to 76 for pfcrt; 51, 59, 108, and 164 for pfdhfr; 540, 581, and 613 for pfdhps; and 86, 184, 1034, 1042, and 1246 for pfmdr1, and four of these carried the K540E pfdhps allele. The pfmdr1 D1246Y mutation was associated with PCR-corrected day 42 in vivo treatment failure in children allocated piperaquine-dihydroartemisinin (P = 0.004). Although the pfmdr1 NFSDD haplotype was found in only four isolates, it has been associated with artemether-lumefantrine treatment failure in Africa. LDR-FMA allows the large-scale assessment of resistance-associated single-nucleotide polymorphisms (SNPs). Our findings reflect previous heavy 4-aminoquinoline/sulfadoxine-pyrimethamine use in PNG. Since artemether-lumefantrine and piperaquine-dihydroartemisinin will become first- and second-line treatments, respectively, the monitoring of pfmdr1 SNPs appears to be a high priority. 相似文献
994.
995.
996.
While elevated low-density lipoprotein cholesterol is the primary target of hypercholesterolemia treatment, high triglycerides and low high-density lipoprotein cholesterol are also important targets for therapy. Correcting these lipid abnormalities should be an integral part of therapy in hypertensive individuals. Medications such as the fibrates are effective and well tolerated for reducing triglycerides and increasing high-density lipoprotein cholesterol, and their use has resulted in a reduction in cardiovascular events. Fibrates are also recommended as adjunct therapy for patients receiving statins whose low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol is not reduced to goal levels. The combination of a statin and a fibrate may, however, raise the risk of myopathy and rhabdomyolysis. Gemfibrozil, one of the fibrates, but not fenofibrate, interferes with statin glucuronidation, which may increase the risk of myopathy due to elevations in statin serum levels. This may at least partially explain the lower incidence of myopathy with fenofibrate compared with gemfibrozil when combined with statins. Combination therapy with a fibrate and a statin is a potentially useful therapy for patients with atherogenic lipid profiles, for which fenofibrate appears to be a more appropriate choice due to less myopathic potential. 相似文献
997.
Williams GC Dunnington KM Hu MY Zimmerman TR Wang Z Hafner KB Stoltz M Hill EK Barbey JT 《Journal of cardiovascular electrophysiology》2006,17(4):352-358
INTRODUCTION: The effect of standing on heart rate and QT is well known but its impact on QTc is less clear. METHODS: Serial supine and standing 12-lead ECGs (seven pairs each day) were recorded from 54 healthy volunteers each day of a three-day period. ECGs were captured digitally and over-read by a cardiologist. RESULTS: A statistically significant shortening of RR (216 ms), QT (40 ms), and decreases in QTc-F (Fridericia) and QTc-LR (Framingham) were demonstrated on standing (8.3 and 6.9 ms, respectively). In contrast, QTc-B (Bazett's) significantly increased by 9.6 ms. Two subject-individualized correction methods were derived using each subject's supine measurements. Both showed significant decreases in QTc of approximately 13-14 ms upon standing. Using the bin analysis method, comparisons between positions using 25 ms interval RR bins revealed significant QT shortening of up to 15 ms upon standing. CONCLUSION: We have demonstrated a postural effect on cardiac repolarization independent of heart rate using two individualized correction methods, as well as QTc-F and QTc-LR, and the bin method. Characterization of postural differences in QT/QTc (other than QTc-B) may provide a safe and inexpensive physiological control to validate the ECG methodology used in clinical trials to assess potential drug-induced QT interval changes. 相似文献
998.
Interactions between platelets and leukocytes link critical thrombotic and inflammatory events that control an array of cardiovascular syndromes. In atherosclerosis alone, inducible gene expression in platelets and leukocytes modulates the initiation and development of vulnerable plaques that increase a patient's risk for acute coronary events. Interruption of gene expression pathways that are triggered when platelets adhere to leukocytes may be a new target for therapeutic intervention. Recent evidence indicates that dipyridamole, an old drug with a diverse history, differentially inhibits gene expression in platelet-leukocyte aggregates by exerting its effect at distinct molecular checkpoints. 相似文献
999.
1000.
Meert KL Donaldson AE Newth CJ Harrison R Berger J Zimmerman J Anand KJ Carcillo J Dean JM Willson DF Nicholson C Shear K;Eunice Kennedy Shriver National Institute of Child Health Human Development Collaborative Pediatric Critical Care Research Network 《Archives of pediatrics & adolescent medicine》2010,164(11):1045-1051